For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Prednisolone | prednisolone 5 mg per day Prednisolone: capsules 5 mg / day | 3 | None | 55 | 224 | 169 | 224 | View |
| Placebo | placebo capsules once per day Placebo: capsules 1 / day | 2 | None | 46 | 225 | 164 | 225 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| melanoma | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Meddra 21.0 | View |
| pancreas carcinoma | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Meddra 21.0 | View |
| renal cell carcinoma | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Meddra 21.0 | View |
| prostate cancer | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Meddra 21.0 | View |
| rectal cancer | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Meddra 21.0 | View |
| urothelium transitional cell carcinoma | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Meddra 21.0 | View |
| carotid atherosclerosis | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | Meddra 21.0 | View |
| cerebrovascular accident | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | Meddra 21.0 | View |
| complex regional pain syndrome | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | Meddra 21.0 | View |
| facial paralysis | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | Meddra 21.0 | View |
| headache | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | Meddra 21.0 | View |
| neuralgia, intercostal | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | Meddra 21.0 | View |
| radicular syndrome | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | Meddra 21.0 | View |
| syncope | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | Meddra 21.0 | View |
| transient ischemic attack | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | Meddra 21.0 | View |
| intracranial hemorrhage, traumatic | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | Meddra 21.0 | View |
| Vertebrobasilar insufficiency | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | Meddra 21.0 | View |
| depression | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | Meddra 21.0 | View |
| dementia, neuropsychiatric symptoms | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | Meddra 21.0 | View |
| chronic obstructive pulmonary disease | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | Meddra 21.0 | View |
| dyspnea | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | Meddra 21.0 | View |
| hyperventilation | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | Meddra 21.0 | View |
| pleural effusion | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | Meddra 21.0 | View |
| pneumonitis | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | Meddra 21.0 | View |
| cough, productive | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | Meddra 21.0 | View |
| pulmonary embolism | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | Meddra 21.0 | View |
| skin ulcer | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | Meddra 21.0 | View |
| total hip replacement | NON_SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | Meddra 21.0 | View |
| thyroidectomy | NON_SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | Meddra 21.0 | View |
| prostatectomy, transurethral | NON_SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | Meddra 21.0 | View |
| circulatory collapse | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | Meddra 21.0 | View |
| hypertensive crisis | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | Meddra 21.0 | View |
| hyperglycemia | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | Meddra 21.0 | View |
| arthritis | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | Meddra 21.0 | View |
| intravertebral disc protrusion | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | Meddra 21.0 | View |
| osteoarthritis | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | Meddra 21.0 | View |
| lung carcinoma | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Meddra 21.0 | View |
| B-cell lymphoma | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Meddra 21.0 | View |
| basal cell carinoma | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Meddra 21.0 | View |
| epenymoma | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Meddra 21.0 | View |
| gastrointestinal stromal tumor | NON_SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Meddra 21.0 | View |
| contusion | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | Meddra 21.0 | View |
| spine fracture | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | Meddra 21.0 | View |
| AV block | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | Meddra 21.0 | View |
| malaise | NON_SYSTEMATIC_ASSESSMENT | General disorders | Meddra 21.0 | View |
| appendicitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | Meddra 21.0 | View |
| sepsis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | Meddra 21.0 | View |
| epidydimitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | Meddra 21.0 | View |
| chesst discomfort/pain | NON_SYSTEMATIC_ASSESSMENT | General disorders | Meddra 21.0 | View |
| pyrexia | NON_SYSTEMATIC_ASSESSMENT | General disorders | Meddra 21.0 | View |
| abcess limb | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | Meddra 21.0 | View |
| bursitis infective | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | Meddra 21.0 | View |
| covid-19 pneumonia | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | Meddra 21.0 | View |
| diverticulitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | Meddra 21.0 | View |
| erysipelas | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | Meddra 21.0 | View |
| fungal infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | Meddra 21.0 | View |
| gastroenteritis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | Meddra 21.0 | View |
| infectious pleural effusion | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | Meddra 21.0 | View |
| parainfluenzae infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | Meddra 21.0 | View |
| gastroenteritis, parasitic | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | Meddra 21.0 | View |
| septic shock | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | Meddra 21.0 | View |
| pneumonia | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | Meddra 21.0 | View |
| pyelonephritis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | Meddra 21.0 | View |
| salmonellosis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | Meddra 21.0 | View |
| upper respiratory tract infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | Meddra 21.0 | View |
| urinary tract infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | Meddra 21.0 | View |
| Postoperative abscess Hematoma infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | Meddra 21.0 | View |
| peritonitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | Meddra 21.0 | View |
| hip fracture | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | Meddra 21.0 | View |
| multiple fractures | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | Meddra 21.0 | View |
| pelvic fracture | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | Meddra 21.0 | View |
| synovial rupture | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | Meddra 21.0 | View |
| tendon rupture | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | Meddra 21.0 | View |
| prostate specific antigen increased | NON_SYSTEMATIC_ASSESSMENT | Investigations | Meddra 21.0 | View |
| weight decrease | NON_SYSTEMATIC_ASSESSMENT | Investigations | Meddra 21.0 | View |
| decreased appetite | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | Meddra 21.0 | View |
| dehydration | NON_SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | Meddra 21.0 | View |
| urinary tract obstruction | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | Meddra 21.0 | View |
| asthma | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | Meddra 21.0 | View |
| myocardial infarction | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | Meddra 21.0 | View |
| myocardial ischemia | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | Meddra 21.0 | View |
| atrial fibrillation/flutter | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | Meddra 21.0 | View |
| cardiac failure | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | Meddra 21.0 | View |
| aortic valve stenosis | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | Meddra 21.0 | View |
| hyperthyroidism | NON_SYSTEMATIC_ASSESSMENT | Endocrine disorders | Meddra 21.0 | View |
| cataract | NON_SYSTEMATIC_ASSESSMENT | Eye disorders | Meddra 21.0 | View |
| abdominal pain | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | Meddra 21.0 | View |
| constipation | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | Meddra 21.0 | View |
| diarrhea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | Meddra 21.0 | View |
| diverticular perforation | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | Meddra 21.0 | View |
| lower gastrointestinal hemorrhage | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | Meddra 21.0 | View |
| enteritis | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | Meddra 21.0 | View |
| small intestinal obstruction | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | Meddra 21.0 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| all nonserious events | NON_SYSTEMATIC_ASSESSMENT | General disorders | Meddra 21.0 | View |
| bronchitis, nasopharyngitis, respiratory tract infection | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | Meddra 21.0 | View |
| urinary tract infection, cystitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | Meddra 21.0 | View |
| influenza, influenza-like illness | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | Meddra 21.0 | View |
| pneumonia | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | Meddra 21.0 | View |
| hypertension | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | Meddra 21.0 | View |
| headache | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | Meddra 21.0 | View |
| cough | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | Meddra 21.0 | View |